Abstract
Vascular endothelial growth factor C (VEGF-C) was first identified as a regulator of the vascular system, where it is required for the development of lymphatic vessels. Here we report actions of VEGF-C in the central nervous system. We detected the expression of the VEGF-C receptor VEGFR-3 in neural progenitor cells in Xenopus laevis and mouse embryos. In Xenopus tadpole VEGF-C knockdowns and in mice lacking Vegfc, the proliferation of neural progenitors expressing VEGFR-3 was severely reduced, in the absence of intracerebral blood vessel defects. In addition, Vegfc-deficient mouse embryos showed a selective loss of oligodendrocyte precursor cells (OPCs) in the embryonic optic nerve. In vitro, VEGF-C stimulated the proliferation of OPCs expressing VEGFR-3 and nestin-positive ventricular neural cells. VEGF-C thus has a new, evolutionary conserved function as a growth factor selectively required by neural progenitor cells expressing its receptor VEGFR-3.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Tissue-type plasminogen activator exerts EGF-like chemokinetic effects on oligodendrocytes in white matter (re)myelination
Molecular Neurodegeneration Open Access 23 February 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Hogan, K.A., Ambler, C.A., Chapman, D.L. & Bautch, V.L. The neural tube patterns vessels developmentally using the VEGF signaling pathway. Development 131, 1503–1513 (2004).
Palmer, T.D., Willhoite, A.R. & Gage, F.H. Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol. 425, 479–494 (2000).
Cao, L. et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet. 36, 827–835 (2004).
Mi, H., Haeberle, H. & Barres, B.A. Induction of astrocyte differentiation by endothelial cells. J. Neurosci. 21, 1538–1547 (2001).
Louissaint, A., Jr ., Rao, S., Leventhal, C. & Goldman, S.A. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron 34, 945–960 (2002).
Shen, Q. et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338–1340 (2004).
Carmeliet, P. Blood vessels and nerves: common signals, pathways and diseases. Nat. Rev. Genet. 4, 710–720 (2003).
Klagsbrun, M. & Eichmann, A. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev. 16, 535–548 (2005).
Ferrara, N., Gerber, H.P. & LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 9, 669–676 (2003).
Breier, G., Albrecht, U., Sterrer, S. & Risau, W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521–532 (1992).
Ogunshola, O.O. et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 277, 11410–11415 (2002).
Yang, K. & Cepko, C.L. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J. Neurosci. 16, 6089–6099 (1996).
Yourey, P.A., Gohari, S., Su, J.L. & Alderson, R.F. Vascular endothelial cell growth factors promote the in vitro development of rat photoreceptor cells. J. Neurosci. 20, 6781–6788 (2000).
Jin, K. et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA 99, 11946–11950 (2002).
Schanzer, A. et al. Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 14, 237–248 (2004).
Sondell, M., Lundborg, G. & Kanje, M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19, 5731–5740 (1999).
Oosthuyse, B. et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28, 131–138 (2001).
Lambrechts, D. et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34, 383–394 (2003).
Sondell, M., Sundler, F. & Kanje, M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 12, 4243–4254 (2000).
Joukov, V. et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 1751 (1996).
Lee, J. et al. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. USA 93, 1988–1992 (1996).
Jeltsch, M. et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423–1425 (1997).
Kaipainen, A. et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566–3570 (1995).
Jussila, L. & Alitalo, K. Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82, 673–700 (2002).
Karkkainen, M.J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5, 74–80 (2004).
Ny, A. et al. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat. Med. 11, 998–1004 (2005).
Dumont, D.J. et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946–949 (1998).
Rowitch, D.H., Lu, Q.R., Kessaris, N. & Richardson, W.D. An 'oligarchy' rules neural development. Trends Neurosci. 25, 417–422 (2002).
Shi, J., Marinovich, A. & Barres, B.A. Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve. J. Neurosci. 18, 4627–4636 (1998).
Small, R.K., Riddle, P. & Noble, M. Evidence for migration of oligodendrocyte–type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature 328, 155–157 (1987).
Mi, H. & Barres, B.A. Purification and characterization of astrocyte precursor cells in the developing rat optic nerve. J. Neurosci. 19, 1049–1061 (1999).
Barres, B.A. et al. Cell death in the oligodendrocyte lineage. J. Neurobiol. 23, 1221–1230 (1992).
Spassky, N. et al. Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. J. Neurosci. 22, 5992–6004 (2002).
Darland, D.C. et al. Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev. Biol. 264, 275–288 (2003).
Avantaggiato, V., Orlandini, M., Acampora, D., Oliviero, S. & Simeone, A. Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family. Mech. Dev. 73, 221–224 (1998).
Joukov, V. et al. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J. Biol. Chem. 273, 6599–6602 (1998).
Kirkin, V. et al. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Eur. J. Biochem. 268, 5530–5540 (2001).
Richardson, W.D., Pringle, N., Mosley, M.J., Westermark, B. & Dubois-Dalcq, M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53, 309–319 (1988).
Noble, M., Murray, K., Stroobant, P., Waterfield, M.D. & Riddle, P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333, 560–562 (1988).
Buchdunger, E. et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 295, 139–145 (2000).
Stolt, C.C. et al. The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. 17, 1677–1689 (2003).
Schratzberger, P. et al. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med. 6, 405–413 (2000).
Fruttiger, M. et al. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126, 457–467 (1999).
Klinghoffer, R.A., Hamilton, T.G., Hoch, R. & Soriano, P. An allelic series at the PDGFalphaR locus indicates unequal contributions of distinct signaling pathways during development. Dev. Cell 2, 103–113 (2002).
Mudhar, H.S., Pollock, R.A., Wang, C., Stiles, C.D. & Richardson, W.D. PDGF and its receptors in the developing rodent retina and optic nerve. Development 118, 539–552 (1993).
Spassky, N. et al. Multiple restricted origin of oligodendrocytes. J. Neurosci. 18, 8331–8343 (1998).
Nieuwkoop, P.J.F.J. (ed.) Normal Table of Xenopus Laevis (Daudin): A Systematical and Chronological Survey of the Development from the Fertilized Egg till the End of Metamorphosis (Garand Publishing, New York, 1994).
Shibata, T. et al. Glutamate transporter GLAST is expressed in the radial gliaastrocyte lineage of developing mouse spinal cord. J. Neurosci. 17, 9212–9219 (1997).
Sun, T. et al. Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex. J. Neurosci. 23, 9547–9556 (2003).
Acknowledgements
We thank A. Williams, K. Heydon and P. Topilko for critically reading the manuscript and A. Chedotal for discussions. Glivec was provided by Novartis International AG and anti-Sox9 Ab by M. Wegner. This work was supported by Institut National de la Santé et de la Recherche Médicale (INSERM; J.-L.T., B.Z., M.-J.B., A.E.), Ministère de l'éducation nationale, de l'enseignement supérieur et de la recherche (MENESR; A.E., J.-L.T.), European Community (Lymphangiogenomics LSHG-CT-2004-503573 to K.A., P.C., A.E.), the US National Institutes of Health (R01 HL075183-02 to K.A.), the Academy of Finland (K.A., M.J.K.), the Association pour la Recherche de la Sclérose en Plaques (ARSEP) and Association Européenne contre les Leucodystrophies (ELA) (J.-L.T.), Association pour la Recherche sur la Cancer (ARC, A.E.), and the Novo Nordisk Foundation (K.A.). B.L.B was a fellow of MENESR, the Fondation Recherche Médicale (FRM) and the Ligue Française contre la Sclérose En Plaques (LFSEP). L.Y. was supported by Fondation Schlumberger. A.N was sponsored by a Marie Curie Intra-European Fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
VEGF-C requirement for neural development in Xenopus tadpoles. (PDF 631 kb)
Supplementary Fig. 2
VEGFR-3 and VEGF-C expression in the embryonic mouse brain. (PDF 1221 kb)
Supplementary Fig. 3
VEGF-C promotes oligodendrogenesis in the embryonic ventral forebrain. (PDF 248 kb)
Rights and permissions
About this article
Cite this article
Le Bras, B., Barallobre, MJ., Homman-Ludiye, J. et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat Neurosci 9, 340–348 (2006). https://doi.org/10.1038/nn1646
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn1646
This article is cited by
-
Tissue-type plasminogen activator exerts EGF-like chemokinetic effects on oligodendrocytes in white matter (re)myelination
Molecular Neurodegeneration (2017)
-
A neuronal PI(3,4,5)P3-dependent program of oligodendrocyte precursor recruitment and myelination
Nature Neuroscience (2017)
-
Angiocrine functions of organ-specific endothelial cells
Nature (2016)
-
Elevated Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Patients with Mesial Temporal Lobe Epilepsy
Journal of Molecular Neuroscience (2016)
-
Research advances in HMGN5 and cancer
Tumor Biology (2016)